Blocking the docking of HIV-1

被引：12

作者：

McKnight, D ^{[1
]}

Weiss, RA ^{[1
]}

机构：

[1] UCL, Dept Immunol & Mol Pathol, London W1T 4JF, England

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2003年 / 100卷 / 19期

关键词：

D O I：

10.1073/pnas.2035071100

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：10581 / 10582

页数：2

共 17 条

[1] Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].

Berger, EA ;

Murphy, PM ;

Farber, JM .

ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700

[2] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].

BURTON, DR ;

PYATI, J ;

KODURI, R ;

SHARP, SJ ;

THORNTON, GB ;

PARREN, PWHI ;

SAWYER, LSW ;

HENDRY, RM ;

DUNLOP, N ;

NARA, PL ;

LAMACCHIA, M ;

GARRATTY, E ;

STIEHM, ER ;

BRYSON, YJ ;

CAO, YZ ;

MOORE, JP ;

HO, DD ;

BARBAS, CF .

SCIENCE, 1994, 266 (5187) :1024-1027

[3] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].

DAAR, ES ;

LI, XL ;

MOUDGIL, T ;

HO, DD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6574-6578

[4] THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].

DALGLEISH, AG ;

BEVERLEY, PCL ;

CLAPHAM, PR ;

CRAWFORD, DH ;

GREAVES, MF ;

WEISS, RA .

NATURE, 1984, 312 (5996) :763-767

[5] Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype [J].

Dumonceaux, J ;

Nisole, S ;

Chanel, C ;

Quivet, L ;

Amara, A ;

Baleux, F ;

Briand, P ;

Hazan, U .

JOURNAL OF VIROLOGY, 1998, 72 (01) :512-519

[6] Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein [J].

Hoffman, TL ;

LaBranche, CC ;

Zhang, WT ;

Canziani, G ;

Robinson, J ;

Chaiken, I ;

Hoxie, JA ;

Doms, RW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6359-6364

[7] Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults [J].

Jacobson, JM ;

Lowy, I ;

Fletcher, CV ;

O'Neill, TJ ;

Tran, DNH ;

Ketas, TJ ;

Trkola, A ;

Klotman, ME ;

Maddon, PJ ;

Olson, WC ;

Israel, RJ .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :326-329

[8] LYMPHOCYTE-T T4 MOLECULE BEHAVES AS THE RECEPTOR FOR HUMAN RETROVIRUS LAV [J].

KLATZMANN, D ;

CHAMPAGNE, E ;

CHAMARET, S ;

GRUEST, J ;

GUETARD, D ;

HERCEND, T ;

GLUCKMAN, JC ;

MONTAGNIER, L .

NATURE, 1984, 312 (5996) :767-768

[9] Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication [J].

Kolchinsky, P ;

Mirzabekov, T ;

Farzan, M ;

Kiprilov, E ;

Cayabyab, M ;

Mooney, LJ ;

Choe, H ;

Sodroski, J .

JOURNAL OF VIROLOGY, 1999, 73 (10) :8120-8126

[10] Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].

Kwong, PD ;

Wyatt, R ;

Robinson, J ;

Sweet, RW ;

Sodroski, J ;

Hendrickson, WA .

NATURE, 1998, 393 (6686) :648-659

← 1 2 →